| Sep 3 |
Heron Therapeutics Announces Appointment of Brett Fleshman as Chief Business Officer
|
| Aug 9 |
Heron Therapeutics, Inc., (HRTX) Q2 2024 Earnings Call Transcript
|
| Aug 9 |
Heron Therapeutics, Inc. 2024 Q2 - Results - Earnings Call Presentation
|
| Aug 8 |
Heron Therapeutics Second Quarter 2024 Earnings: EPS Misses Expectations
|
| Aug 6 |
Heron Therapeutics (HRTX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
|
| Aug 6 |
Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates
|
| Aug 6 |
Heron Therapeutics: Q2 Earnings Snapshot
|
| Aug 6 |
Heron Therapeutics GAAP EPS of -$0.06 misses by $0.02, revenue of $36.02M beats by $0.13M
|
| Aug 6 |
Heron Therapeutics Announces Second Quarter 2024 Financial Results and Narrows Financial Guidance
|
| Aug 5 |
Heron Therapeutics Q2 2024 Earnings Preview
|
